197 related articles for article (PubMed ID: 38363492)
1. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma.
Sheehan JP; Mantziaris G; Bunevicius A
J Neurooncol; 2024 Mar; 167(1):231-232. PubMed ID: 38363492
[No Abstract] [Full Text] [Related]
2. Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme.
Cabrera AR; Cuneo KC; Vredenburgh JJ; Sampson JH; Kirkpatrick JP
J Natl Compr Canc Netw; 2012 Jun; 10(6):695-9. PubMed ID: 22679114
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma.
Zhang JF; Okai B; Iovoli A; Goulenko V; Attwood K; Lim J; Hess RM; Abad AP; Prasad D; Fenstermaker RA
J Neurooncol; 2024 Jan; 166(1):89-98. PubMed ID: 38175460
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and limitations of stereotactic radiosurgery in the treatment of glioblastoma.
Koga T; Saito N
Neurol Med Chir (Tokyo); 2012; 52(8):548-52. PubMed ID: 22976136
[TBL] [Abstract][Full Text] [Related]
5. Recent therapeutic advances and insights of recurrent glioblastoma multiforme.
Chen J; Xu T
Front Biosci (Landmark Ed); 2013 Jan; 18(2):676-84. PubMed ID: 23276952
[TBL] [Abstract][Full Text] [Related]
6. Salvage stereotactic radiosurgery with adjuvant use of bevacizumab for heavily treated recurrent brain metastases: a preliminary report.
Yomo S; Hayashi M
J Neurooncol; 2016 Mar; 127(1):119-26. PubMed ID: 26619997
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab plus irinotecan in recurrent glioblastoma.
Chamberlain MC
J Clin Oncol; 2008 Feb; 26(6):1012-3; author reply 1013. PubMed ID: 18281677
[No Abstract] [Full Text] [Related]
8. Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study.
Park KJ; Kano H; Iyer A; Liu X; Niranjan A; Flickinger JC; Lieberman FS; Lunsford LD; Kondziolka D
J Neurooncol; 2012 Apr; 107(2):323-33. PubMed ID: 22057917
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated Radiosurgery Plus Bevacizumab for Locally Recurrent Brain Metastasis with Previously High-Dose Irradiation.
Guan Y; Wang C; Zhu H; Li J; Xu W; Sun L; Pan L; Dai J; Wang Y; Wang E; Wang X
World Neurosurg; 2020 Jan; 133():e252-e258. PubMed ID: 31505283
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.
Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034
[TBL] [Abstract][Full Text] [Related]
11. The role of radiotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.
Ryu S; Buatti JM; Morris A; Kalkanis SN; Ryken TC; Olson JJ;
J Neurooncol; 2014 Jul; 118(3):489-99. PubMed ID: 24728785
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme.
Mantica M; Drappatz J; Lieberman F; Hadjipanayis CG; Lunsford LD; Niranjan A
J Neurooncol; 2023 Aug; 164(1):179-190. PubMed ID: 37515669
[TBL] [Abstract][Full Text] [Related]
13. Early assessment of recurrent glioblastoma response to bevacizumab treatment by diffusional kurtosis imaging: a preliminary report.
Lee CY; Kalra A; Spampinato MV; Tabesh A; Jensen JH; Helpern JA; de Fatima Falangola M; Van Horn MH; Giglio P
Neuroradiol J; 2019 Oct; 32(5):317-327. PubMed ID: 31282311
[TBL] [Abstract][Full Text] [Related]
14. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
[TBL] [Abstract][Full Text] [Related]
15. Outcomes after stereotactic radiosurgery and various adjuvant treatments for recurrent glioblastoma multiforme: a current literature review and comparison of multiple factors that impact outcome.
Murovic JA; Chang SD
World Neurosurg; 2012 Dec; 78(6):588-91. PubMed ID: 22705758
[No Abstract] [Full Text] [Related]
16. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.
Gutin PH; Iwamoto FM; Beal K; Mohile NA; Karimi S; Hou BL; Lymberis S; Yamada Y; Chang J; Abrey LE
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):156-63. PubMed ID: 19167838
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery for glioblastoma--time to revisit this approach.
Sheehan J
World Neurosurg; 2012 Dec; 78(6):592-3. PubMed ID: 22641184
[No Abstract] [Full Text] [Related]
18. Stereotactic Radiosurgery in the Multimodality Management of Residual or Recurrent Glioblastoma Multiforme.
Niranjan A; Monaco EA; Kano H; Flickinger JC; Lunsford LD
Prog Neurol Surg; 2018; 31():48-61. PubMed ID: 29393176
[TBL] [Abstract][Full Text] [Related]
19. Gamma Knife Stereotactic Radiosurgery in Combination with Bevacizumab for Recurrent Glioblastoma.
Morris SL; Zhu P; Rao M; Martir M; Zhu JJ; Hsu S; Ballester LY; Day AL; Tandon N; Kim DH; Shepard S; Blanco A; Esquenazi Y
World Neurosurg; 2019 Jul; 127():e523-e533. PubMed ID: 30954746
[TBL] [Abstract][Full Text] [Related]
20. Rechallenging Recurrent Glioblastoma with Intra-Arterial Bevacizumab with Blood Brain-Barrier Disruption Results in Radiographic Response.
Faltings L; Kulason KO; Patel NV; Wong T; Fralin S; Li M; Schneider JR; Filippi CG; Langer DJ; Ortiz R; Boockvar JA
World Neurosurg; 2019 Nov; 131():234-241. PubMed ID: 31351210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
